Fosavance (alendronate + colecalciferol)

BNF:: 6.6.2
Status:: Grey
Decision Date:: None

Comments

Brown Drug Classifications

1: Lack of data on effectiveness compared with standard therapy
5: Less cost-effective than current standard therapy